148 related articles for article (PubMed ID: 37428612)
1. Establishment of a Novel Anti-Human CCR6 Monoclonal Antibody C
Tanaka T; Kitamura K; Suzuki H; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2023 Aug; 42(4):117-124. PubMed ID: 37428612
[TBL] [Abstract][Full Text] [Related]
2. Development of a Novel Anti-Mouse CCR6 Monoclonal Antibody (C
Asano T; Tanaka T; Suzuki H; Li G; Nanamiya R; Tateyama N; Isoda Y; Okada Y; Kobayashi H; Yoshikawa T; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Dec; 41(6):343-349. PubMed ID: 36383115
[TBL] [Abstract][Full Text] [Related]
3. Identification of the Binding Epitope of an Anti-Mouse CCR6 Monoclonal Antibody (C
Tanaka T; Tawara M; Suzuki H; Kaneko MK; Kato Y
Antibodies (Basel); 2023 Apr; 12(2):. PubMed ID: 37218898
[TBL] [Abstract][Full Text] [Related]
4. Amino terminal recognition by a CCR6 chemokine receptor antibody blocks CCL20 signaling and IL-17 expression via β-arrestin.
Gómez-Melero S; García-Maceira FI; García-Maceira T; Luna-Guerrero V; Montero-Peñalvo G; Túnez-Fiñana I; Paz-Rojas E
BMC Biotechnol; 2021 Jul; 21(1):41. PubMed ID: 34225700
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a Sensitive Monoclonal Antibody Against Mouse CCR9 (C
Kobayashi H; Asano T; Suzuki H; Tanaka T; Yoshikawa T; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2023 Feb; 42(1):15-21. PubMed ID: 36516144
[TBL] [Abstract][Full Text] [Related]
6. Development of a Sensitive Anti-Human CCR9 Monoclonal Antibody (C
Tanaka T; Suzuki H; Isoda Y; Asano T; Nakamura T; Yanaka M; Handa S; Takahashi N; Okuno S; Yoshikawa T; Li G; Nanamiya R; Goto N; Tateyama N; Okada Y; Kobayashi H; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Dec; 41(6):303-310. PubMed ID: 36383113
[TBL] [Abstract][Full Text] [Related]
7. Cx
Kitamura K; Suzuki H; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Jun; 41(3):133-141. PubMed ID: 35736626
[TBL] [Abstract][Full Text] [Related]
8. Establishment of Novel Anti-Mouse CCR3 Monoclonal Antibodies (C
Asano T; Suzuki H; Goto N; Tanaka T; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Apr; 41(2):94-100. PubMed ID: 35471054
[TBL] [Abstract][Full Text] [Related]
9. Specific binding and chemotactic activity of mBD4 and its functional orthologue hBD2 to CCR6-expressing cells.
Röhrl J; Yang D; Oppenheim JJ; Hehlgans T
J Biol Chem; 2010 Mar; 285(10):7028-34. PubMed ID: 20068036
[TBL] [Abstract][Full Text] [Related]
10. Cx
Li G; Tanaka T; Ouchida T; Kaneko MK; Suzuki H; Kato Y
Monoclon Antib Immunodiagn Immunother; 2024 Apr; 43(2):59-66. PubMed ID: 38593439
[TBL] [Abstract][Full Text] [Related]
11. Development of Anti-Human CC Chemokine Receptor 9 Monoclonal Antibodies for Flow Cytometry.
Nanamiya R; Takei J; Asano T; Tanaka T; Sano M; Nakamura T; Yanaka M; Hosono H; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2021 Jun; 40(3):101-106. PubMed ID: 34161159
[TBL] [Abstract][Full Text] [Related]
12. Development of a Novel Anti-Mouse CCR2 Monoclonal Antibody (C
Tanaka T; Li G; Asano T; Saito M; Kaneko MK; Suzuki H; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Apr; 41(2):80-86. PubMed ID: 35377242
[TBL] [Abstract][Full Text] [Related]
13. C
Asano T; Suzuki H; Tanaka T; Saito M; Li G; Goto N; Nanamiya R; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Apr; 41(2):74-79. PubMed ID: 35471049
[TBL] [Abstract][Full Text] [Related]
14. Cx
Ouchida T; Isoda Y; Tanaka T; Kaneko MK; Suzuki H; Kato Y
Monoclon Antib Immunodiagn Immunother; 2024 Jun; 43(3):90-95. PubMed ID: 38507670
[TBL] [Abstract][Full Text] [Related]
15. Cx
Ouchida T; Suzuki H; Tanaka T; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2024 Feb; 43(1):10-16. PubMed ID: 38126879
[TBL] [Abstract][Full Text] [Related]
16. Corneal epithelial cells and stromal keratocytes efficently produce CC chemokine-ligand 20 (CCL20) and attract cells expressing its receptor CCR6 in mouse herpetic stromal keratitis.
Shirane J; Nakayama T; Nagakubo D; Izawa D; Hieshima K; Shimomura Y; Yoshie O
Curr Eye Res; 2004 May; 28(5):297-306. PubMed ID: 15287366
[TBL] [Abstract][Full Text] [Related]
17. Essential role for CCR6 in certain inflammatory diseases demonstrated using specific antagonist and knockin mice.
Robert R; Ang C; Sun G; Juglair L; Lim EX; Mason LJ; Payne NL; Bernard CC; Mackay CR
JCI Insight; 2017 Aug; 2(15):. PubMed ID: 28768901
[TBL] [Abstract][Full Text] [Related]
18. Development of a Novel Anti-Mouse CCR4 Monoclonal Antibody (C
Takei J; Suzuki H; Asano T; Tanaka T; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Apr; 41(2):87-93. PubMed ID: 35471046
[TBL] [Abstract][Full Text] [Related]
19. C
Saito M; Suzuki H; Harigae Y; Li G; Tanaka T; Asano T; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Apr; 41(2):120-124. PubMed ID: 35471047
[TBL] [Abstract][Full Text] [Related]
20. The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease.
Dohlman TH; Chauhan SK; Kodati S; Hua J; Chen Y; Omoto M; Sadrai Z; Dana R
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4081-91. PubMed ID: 23702781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
